Thus SYNJ2 may play diverse roles in LUSC, lung adenocarcinoma, and small cell lung cancer, while the study of Ben-Chetrit et al. concentrated on all lung cancer rather than specific subtypes was not sufficient to understand the full spectrum of functions and mechanisms of action of SYNJ2 in LUSC. Here, SYNJ2 is linked to lung adenocarcinoma.